Article info
PDFHepatology
Original research
ATF4 activation promotes hepatic mitochondrial dysfunction by repressing NRF1–TFAM signalling in alcoholic steatohepatitis
- Correspondence to Dr Zhanxiang Zhou, Center for Translational Biomedical Research, UNCG, Kannapolis, NC 28081, USA; z_zhou{at}uncg.edu
Citation
ATF4 activation promotes hepatic mitochondrial dysfunction by repressing NRF1–TFAM signalling in alcoholic steatohepatitis
Publication history
- Received April 23, 2020
- Revised October 20, 2020
- Accepted October 21, 2020
- First published November 11, 2020.
Online issue publication
January 10, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.